Morgan Stanley analyst Bob Huang maintained a Buy rating on Globe Life yesterday and set a price target of $179.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bob Huang has given his Buy rating due to a combination of factors that highlight Globe Life’s strong financial performance and promising future outlook. The company has shown consistent earnings growth throughout the year, particularly in its Life and Health segments, which have both exceeded market expectations. The Life segment, in particular, has demonstrated a robust benefit ratio, contributing significantly to the earnings beat. Additionally, the Health segment has experienced substantial year-over-year earnings growth, supported by steady underwriting practices.
Moreover, Globe Life has a track record of surpassing its own guidance, which adds confidence to its projected earnings range for 2026. The company’s guidance aligns closely with current market consensus, yet its history suggests potential for outperforming these expectations. These factors collectively contribute to Bob Huang’s positive outlook on the stock, justifying the Buy rating.
According to TipRanks, Huang is an analyst with an average return of -1.7% and a 47.85% success rate. Huang covers the Financial sector, focusing on stocks such as Progressive, Accelerant Holdings Class A, and Aon.
In another report released yesterday, KBW also maintained a Buy rating on the stock with a $160.00 price target.